Frontiers | MYCN Function in Neuroblastoma Development
An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens | Haematologica
Transcriptional Amplification in Tumor Cells with Elevated c-Myc - ScienceDirect
Oncogene C Myc - an overview | ScienceDirect Topics
Transcriptional amplification - Wikipedia
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat | Signal Transduction and Targeted Therapy
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime? | EMBO Molecular Medicine
N Myc Proto Oncogene Protein - an overview | ScienceDirect Topics
Frontiers | Molecular Mechanisms of MYCN Dysregulation in Cancers
FISH analysis of c-myc (polysomy of 8q and c-myc gene amplification).... | Download Scientific Diagram
MYC - Wikipedia
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells: Cell
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy
Frontiers | Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text
Therapeutic targeting of “undruggable” MYC - eBioMedicine
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy
Genes | Free Full-Text | MYC in Regulating Immunity: Metabolism and Beyond
CytoCell N-MYC (MYCN) Amplification FISH Probe | OGT
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy
Frontiers | Molecular Mechanisms of MYCN Dysregulation in Cancers
C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target | Anticancer Research
Genes | Free Full-Text | The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies | Journal of Hematology & Oncology | Full Text
MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines
